Back

Prevalence of HIV history and associated factors in people affected by mpox in Colombia, 2022

MUNOZ LOZADA, C. M.; MADERO REALES, J. A.; CHAPARRO NARVAEZ, P. E.; PRIETO ALVARADO, F. E.

2025-02-08 public and global health
10.1101/2025.02.05.25321718 medRxiv
Show abstract

The 2022 mpox outbreak disproportionately affected men who have sex with men (MSM) and individuals with history of HIV. This study investigated the prevalence of HIV infection and associated factors among mpox cases in Colombia. A cross-sectional analysis of 4,046 confirmed mpox cases reported to the Public Health Surveillance System between June 25 and December 31, 2022, was conducted. The prevalence of a history of HIV infection in mpox cases was determined, and associated factors were assessed using bivariate and multivariate logistic regression. Most mpox patients were male (97%), with a median age of 31 years (IQR = 27, 37). The most affected age group was 25 to 34 years (52%), and 83.7% were MSM. The prevalence of HIV history was 60%, with the highest rates in Manizales, Medellin, and Itagui. Common symptoms included genital lesions (59.6%) and fever (67.6%). Factors associated with HIV history in mpox patients were male sex [OR = 9.6, 95% CI = 4.35, 21.31], having sexually transmitted infections: hepatitis B [OR = 2.9, 95% CI = 1.91, 4.40], hepatitis C [OR = 7.0, 95% CI = 3.50, 13.97], syphilis [OR = 2.1, 95% CI = 1.46-3.12], hospitalization [OR = 2.2, 95% CI = 1.65, 2.93], Colombian nationality [OR = 2.5, 95% CI = 1.86, 3.48] and being homosexual [OR = 2.5, 95% CI = 2.09, 3.06]. A high prevalence of HIV infection (60%) was found among mpox patients in Colombia, predominantly among MSM. This highlights the need for targeted interventions, such as priority care for people with HIV, active surveillance, and education for timely diagnosis and prevention of complications.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 4%
26.8%
2
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 0.7%
5.0%
3
Tropical Medicine and Infectious Disease
12 papers in training set
Top 0.1%
5.0%
4
PLOS Global Public Health
293 papers in training set
Top 2%
4.5%
5
Journal of Medical Virology
137 papers in training set
Top 0.6%
4.5%
6
PLOS Neglected Tropical Diseases
378 papers in training set
Top 2%
3.7%
7
BMC Infectious Diseases
118 papers in training set
Top 0.9%
3.7%
50% of probability mass above
8
Emerging Infectious Diseases
103 papers in training set
Top 0.7%
3.2%
9
Acta Tropica
13 papers in training set
Top 0.2%
2.8%
10
Cureus
67 papers in training set
Top 2%
2.7%
11
BMC Public Health
147 papers in training set
Top 2%
2.7%
12
Frontiers in Public Health
140 papers in training set
Top 3%
2.1%
13
Travel Medicine and Infectious Disease
15 papers in training set
Top 0.1%
2.0%
14
Vaccines
196 papers in training set
Top 1%
1.8%
15
Virology Journal
25 papers in training set
Top 0.1%
1.8%
16
International Journal of Environmental Research and Public Health
124 papers in training set
Top 4%
1.8%
17
Microbiology Spectrum
435 papers in training set
Top 3%
1.4%
18
Heliyon
146 papers in training set
Top 3%
1.3%
19
Scientific Reports
3102 papers in training set
Top 68%
1.1%
20
JMIR Public Health and Surveillance
45 papers in training set
Top 3%
1.0%
21
Transactions of The Royal Society of Tropical Medicine and Hygiene
16 papers in training set
Top 0.4%
0.9%
22
BMJ Open
554 papers in training set
Top 11%
0.9%
23
Frontiers in Medicine
113 papers in training set
Top 6%
0.8%
24
Sexually Transmitted Infections
21 papers in training set
Top 0.4%
0.8%
25
BMJ Public Health
18 papers in training set
Top 0.9%
0.7%
26
Clinical Microbiology and Infection
60 papers in training set
Top 1%
0.7%
27
Microorganisms
101 papers in training set
Top 3%
0.5%
28
Tropical Medicine & International Health
15 papers in training set
Top 1.0%
0.5%
29
The Journal of Infectious Diseases
182 papers in training set
Top 6%
0.5%
30
Journal of Clinical Medicine
91 papers in training set
Top 8%
0.5%